ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Duke Vice Dean Cuffe Promises Complete, Independent Probe Of Work By Potti, Nevins.

July 30, 2010

NCI High School Summer Program Called Successful

October 19, 1990

SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer

October 28, 2005

Brown Needs Decision By March 31; Sander Decline HEW Offer

March 4, 1977

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

Obey Convinces House Hew Subcommittee to Cut $17 Million Control, Give It To Bioassays

June 1, 1979